
Sign up to save your podcasts
Or


Medication nonadherence is not new, but it remains a persistent, complex problem. Adherence rates hover near 50%—roughly the same as two decades ago—as companies explore new ways to engage patients and help them stick to treatment regimens.
AdhereHealth combines technology with care navigators to identify at-risk patients and help them consistently access their prescriptions.
In this episode of "Podnosis," Fierce Healthcare Senior Writer Anastassia Gliadkovskaya speaks with Chandra Y. Osborn, Ph.D., M.P.H., chief experience officer at AdhereHealth, about how the company takes on risk to drive outcomes and why it keeps a human in the loop.
To learn more about the topics in this episode:
See omnystudio.com/listener for privacy information.
By Fierce Healthcare4.7
33 ratings
Medication nonadherence is not new, but it remains a persistent, complex problem. Adherence rates hover near 50%—roughly the same as two decades ago—as companies explore new ways to engage patients and help them stick to treatment regimens.
AdhereHealth combines technology with care navigators to identify at-risk patients and help them consistently access their prescriptions.
In this episode of "Podnosis," Fierce Healthcare Senior Writer Anastassia Gliadkovskaya speaks with Chandra Y. Osborn, Ph.D., M.P.H., chief experience officer at AdhereHealth, about how the company takes on risk to drive outcomes and why it keeps a human in the loop.
To learn more about the topics in this episode:
See omnystudio.com/listener for privacy information.

4,803 Listeners

4,420 Listeners

1,105 Listeners

30,233 Listeners

2,342 Listeners

343 Listeners

56,944 Listeners

233 Listeners

498 Listeners

9,556 Listeners

337 Listeners

200 Listeners

394 Listeners

688 Listeners

170 Listeners